Head-to-head · WeighScore
Mint Medical Clinic vs Nucific
The verdict
Nucific takes it — 56.2/100 to 55.7/100, but only just.
Nucific grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GLP-1 and NAD+ telehealth founded by triple board-certified physician Dr. Mint Medical Clinic is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mint Medical Clinic | Nucific |
|---|---|---|
| WeighScore | 55.7/100 | 56.2/100 |
| Grade | C | C |
| Scorecard rank | #433 | #417 |
| Semaglutide | $299/mo (compounded) | Not disclosed |
| Tirzepatide | $299/mo (compounded) | Not disclosed |
| Coverage | 1 state | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #433 · C
Strengths
- Hybrid model with an in-person consultation option for patients who prefer physical care
- Parent practice disclosed (Balance Medical Clinic)
- Physical Utah clinic addresses listed on the homepage
- $299/mo flat starting price, competitive with national DTC providers
- Broader scope (sexual health, hormones) may suit patients wanting integrated care
Where it loses points
- Utah only for in-person; telehealth states served not disclosed
- Pharmacy partner not disclosed
- LegitScript certification not mentioned
- 503A vs 503B compounding designation not disclosed
- No named medical director on the homepage
Graded #417 · C
Strengths
- Founder is named and credentialed: Dr. Amy Lee, MD, triple board-certified in Internal Medicine, Obesity Medicine and Clinical Nutrition
- Cites SURMOUNT-1 properly, naming the trial, the 20.9% average and the Jastreboff NEJM 2022 source
- Discloses that featured patients were compensated for their time
- Labels its NAD+ decline chart as illustrative and not a measurement, with an unusually careful methodology note
- Offers compounded, microdosed and brand-name Ozempic and Zepbound in one catalogue
Where it loses points
- No price is published anywhere; every option is gated behind a three-minute quiz
- The LegitScript badge is a self-hosted image with generic alt text rather than the issued embed, so the certification could not be verified
- A BBB Accredited A+ claim is displayed without a link to the BBB profile
- No state list and no named pharmacy, only licensed U.S. pharmacies
- Before-and-after photographs are used alongside compensated testimonials
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.